The invention belongs to the field of pharmaceutical chemicals, and discloses a preparation method of an anti-HIV (
Human Immunodeficiency Virus)
drug intermediate, which comprises the following steps: by taking L-
phenylalanine as a
raw material, synthesizing (3S)-3-(t-butyloxycarboryl) amino-1-chloro-4-phenyl-2-
butanone through the steps of amino protection reaction, chloroacetate
Claisen condensation reaction and the like. Cheap
sodium chloroacetate is adopted as a key
reagent for homogeneity of methyl ester, compared with a traditional preparation process, the method has the advantages of being simple in
process operation, low in
safety risk, small in three-waste emission, low in production cost, high in total yield and the like, used raw materials and intermediate products are low in
toxicity, low in price and easy to obtain, industrial production is easier to achieve, and the production efficiency is improved.